combine@alvar.ug

The effect of facility-based antiretroviral therapy programs on outpatient services in Kenya and Uganda

The effect of facility-based antiretroviral therapy programs on outpatient services in Kenya and Uganda

Show simple record

dc.contributor.author Wollum, Alexandra
dc.contributor.author Dansereau, Emily
dc.contributor.author Fullman, Nancy
dc.contributor.author Achan, Jane
dc.contributor.author Bannon, Kelsey A.
dc.contributor.author Burstein, Roy
dc.contributor.author Conner, Ruben O.
dc.contributor.author DeCenso, Brendan
dc.contributor.author Gasasira, Anne
dc.contributor.author Haakenstad, Annie
dc.contributor.author Hanlon, Michael
dc.contributor.author Ikilezi, Gloria
dc.contributor.author Kisia, Caroline
dc.contributor.author Levine, Aubrey J.
dc.contributor.author Masters, Samuel H.
dc.contributor.author Njuguna, Pamela
dc.contributor.author Okiro, Emelda A.
dc.contributor.author Odeny, Thomas A.
dc.contributor.author Roberts, D. Allen
dc.contributor.author Gakidou, Emmanuela
dc.contributor.author Duber, Herbert C.
dc.date.accessioned 2021-01-01T21:58:03Z
dc.date.available 2021-01-01T21:58:03Z
dc.date.issued 2017
dc.identifier.issn 1472-6963
dc.identifier.uri http://combine.alvar.ug/handle/1/48144
dc.description.abstract Background: Considerable debate exists concerning the effects of antiretroviral therapy (ART) service scale-up on non-HIV services and overall health system performance in sub-Saharan Africa. In this study, we examined whether ART services affected trends in non-ART outpatient department (OPD) visits in Kenya and Uganda. Methods: Using a nationally representative sample of health facilities in Kenya and Uganda, we estimated the effect of ART programs on OPD visits from 2007 to 2012. We modeled the annual percent change in non-ART OPD visits using hierarchical mixed-effects linear regressions, controlling for a range of facility characteristics. We used four different constructs of ART services to capture the different ways in which the presence, growth, overall, and relative size of ART programs may affect non-ART OPD services. Results: Our final sample included 321 health facilities (140 in Kenya and 181 in Uganda). On average, OPD and ART visits increased steadily in Kenya and Uganda between 2007 and 2012. For facilities where ART services were not offered, the average annual increase in OPD visits was 4.2% in Kenya and 13.5% in Uganda. Among facilities that provided ART services, we found average annual OPD volume increases of 7.2% in Kenya and 5.6% in Uganda, with simultaneous annual increases of 13.7% and 12.5% in ART volumes. We did not find a statistically significant relationship between annual changes in OPD services and the presence, growth, overall, or relative size of ART services. However, in a subgroup analysis, we found that Ugandan hospitals that offered ART services had statistically significantly less growth in OPD visits than Ugandan hospitals that did not provide ART services. Conclusions: Our findings suggest that ART services in Kenya and Uganda did not have a statistically significant deleterious effects on OPD services between 2007 and 2012, although subgroup analyses indicate variation by facility type. Our findings are encouraging, particularly given recent recommendations for universal access to ART, demonstrating that expanding ART services is not inherently linked to declines in other health services in sub-Saharan Africa.
dc.description.sponsorship Bill & Melinda Gates FoundationBill & Melinda Gates Foundation
dc.description.sponsorship Disease Control Priorities Network
dc.description.sponsorship NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763, P30AI027763] Funding Source: NIH RePORTER
dc.language English
dc.publisher BMC
dc.relation.ispartof BMC Health Services Research
dc.subject Antiretroviral Therapy
dc.subject Hiv/Aids
dc.subject Health Systems
dc.subject Kenya
dc.subject Uganda
dc.title The effect of facility-based antiretroviral therapy programs on outpatient services in Kenya and Uganda
dc.type Article
dc.identifier.isi 000407825600002
dc.identifier.doi 10.1186/s12913-017-2512-9
dc.identifier.pmid 28814295
dc.publisher.city LONDON
dc.publisher.address CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
dc.identifier.volume 17
dc.subject.wc Health Care Sciences & Services
dc.subject.sc Health Care Sciences & Services
dc.description.oa DOAJ Gold
dc.description.oa Green Published
dc.description.pages 8
dc.subject.kwp Health Systems
dc.subject.kwp National Incidence
dc.subject.kwp Global Burden
dc.subject.kwp Hiv
dc.subject.kwp Disease
dc.subject.kwp Aid
dc.subject.kwp Mortality
dc.identifier.articleno 564
dc.description.affiliation Univ Washington, Inst Hlth Metr & Evaluat, 2301 5th Ave,Suite 600, Seattle, WA 98121 USA
dc.description.affiliation BanjulTheGambia, Med Res Council Unit, Banjul, Gambia
dc.description.affiliation African Leaders Malaria Alliance, Kampala, Uganda
dc.description.affiliation Harvard Sch Publ Hlth, Boston, MA USA
dc.description.affiliation Infect Dis Res Collaborat, Mulago Hosp Complex, Kampala, Uganda
dc.description.affiliation Act Africa Help Int, Nairobi, Kenya
dc.description.affiliation Univ North Carolina Chapel Hill, Chapel Hill, NC USA
dc.description.affiliation Afya Resource Associates, Nairobi, Kenya
dc.description.affiliation Bill & Melinda Gates Fdn, Seattle, WA USA
dc.description.email hduber@uw.edu
dc.description.corr Duber, HC (corresponding author), Univ Washington, Inst Hlth Metr & Evaluat, 2301 5th Ave,Suite 600, Seattle, WA 98121 USA.
dc.description.orcid Roberts, Allen/0000-0003-3660-6330
dc.description.orcid Duber, Herbert/0000-0002-5077-3170
dc.description.orcid Okiro, Emelda/0000-0001-9543-8360


This record appears in the collections of the following institution(s)

Show simple record

Search Entire Database


Browse

My Account